| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
“Antibodies in cancer treatment”
|
Desoize, Bernard
|
|
2007
|
62 |
1 |
p. 23-25
3 p.
|
artikel
|
| 2 |
Editorial Board
|
|
|
2007
|
62 |
1 |
p. CO2-
1 p.
|
artikel
|
| 3 |
EGFR targeting therapies: Monoclonal antibodies versus tyrosine kinase inhibitors
|
Dassonville, Olivier
|
|
2007
|
62 |
1 |
p. 53-61
9 p.
|
artikel
|
| 4 |
FcγR: The key to optimize therapeutic antibodies?
|
Sibéril, Sophie
|
|
2007
|
62 |
1 |
p. 26-33
8 p.
|
artikel
|
| 5 |
Impact of breast cancer survivorship on quality of life in older women
|
Robb, Claire
|
|
2007
|
62 |
1 |
p. 84-91
8 p.
|
artikel
|
| 6 |
Individual differences in well-being in older breast cancer survivors
|
Perkins, Elizabeth A.
|
|
2007
|
62 |
1 |
p. 74-83
10 p.
|
artikel
|
| 7 |
Novel treatment strategies for malignant melanoma: A new beginning?
|
Kasper, Bernd
|
|
2007
|
62 |
1 |
p. 16-22
7 p.
|
artikel
|
| 8 |
Novel treatment strategies for soft tissue sarcoma
|
Kasper, Bernd
|
|
2007
|
62 |
1 |
p. 9-15
7 p.
|
artikel
|
| 9 |
Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force
|
Monfardini, Silvio
|
|
2007
|
62 |
1 |
p. 62-73
12 p.
|
artikel
|
| 10 |
Pharmacokinetics of rituximab and its clinical use: Thought for the best use?
|
Cartron, Guillaume
|
|
2007
|
62 |
1 |
p. 43-52
10 p.
|
artikel
|
| 11 |
Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment
|
Loisel, Severine
|
|
2007
|
62 |
1 |
p. 34-42
9 p.
|
artikel
|
| 12 |
Selection of chemotherapeutic drugs in adjuvant programs based on molecular profiles: Where do we stand?
|
Biganzoli, Laura
|
|
2007
|
62 |
1 |
p. 1-8
8 p.
|
artikel
|
Tijdschrift beschrijving